OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications</p>
Ilaria Puxeddu, Fiorella Petrelli, Francesca Angelotti, et al.
Journal of Asthma and Allergy (2019) Vol. Volume 12, pp. 285-295
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Chronic Urticaria
David M. Lang
New England Journal of Medicine (2022) Vol. 387, Iss. 9, pp. 824-831
Closed Access | Times Cited: 31

Clinical phenotypes and biomarkers in chronic urticaria
Aray Batyrbayeva, Zhanat Ispayeva, M. Pashimov, et al.
Clinica Chimica Acta (2025) Vol. 571, pp. 120233-120233
Closed Access

Biomarkers of chronic spontaneous urticaria and their clinical implications
Riccardo Asero, Massimo Cugno
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 3, pp. 247-254
Closed Access | Times Cited: 25

Identification of key genes and molecular mechanisms of chronic urticaria based on bioinformatics
Haichao Guo, Lifang Guo, Li Li, et al.
Skin Research and Technology (2024) Vol. 30, Iss. 4
Open Access | Times Cited: 3

Mast cell signaling and its role in urticaria
Ilaria Puxeddu, Francesca Pistone, Francesco Pisani, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 4, pp. 374-379
Open Access | Times Cited: 3

Human β-defensin 2: a connection between infections and allergic skin diseases
Maja Štrajtenberger, Asja Stipić-Marković, Ema Barac, et al.
Acta Dermatovenerologica Alpina Pannonica et Adriatica (2024) Vol. 33, Iss. 3
Closed Access | Times Cited: 3

Potential Clinical and Serological Predictors of Chronic Spontaneous Urticaria Relapse in Patients Under Omalizumab Treatment
Teresa Grieco, Laura Dies, Alvise Sernicola, et al.
Immunotherapy (2020) Vol. 12, Iss. 16, pp. 1173-1181
Open Access | Times Cited: 21

Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?
Emek Kocatürk, Emel Bülbül Başkan, Özlem Su Küçük, et al.
Anais Brasileiros de Dermatologia (2022) Vol. 97, Iss. 5, pp. 592-600
Open Access | Times Cited: 13

Advances and novel developments in molecular allergology
Öykü Üzülmez, Tanja Kalic, Heimo Breiteneder
Allergy (2020) Vol. 75, Iss. 12, pp. 3027-3038
Open Access | Times Cited: 18

Key differences between chronic inducible and spontaneous urticaria
Mojca Bizjak, Mitja Košnik
Frontiers in Allergy (2024) Vol. 5
Open Access | Times Cited: 2

A prospective observational study correlating possible novel biomarkers with disease severity and antihistamine response in chronic spontaneous urticaria
Divya Bhatia, Hitaishi Mehta, Anuradha Bishnoi, et al.
Asia Pacific Allergy (2024) Vol. 14, Iss. 1, pp. 5-11
Open Access | Times Cited: 1

Changes in Serum IL-12 Levels following the Administration of H1-Antihistamines in Patients with Chronic Spontaneous Urticaria
Corina Ene, Milena Tocut, Mircea Tampa, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 295-295
Open Access | Times Cited: 1

Chronic spontaneous urticaria
Hai Long, Yue Hu, Liting He
Elsevier eBooks (2024), pp. 1301-1331
Closed Access | Times Cited: 1

Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients
Cristina López, Nathalie Depreux, Isabel Bielsa, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

Improving of psychological status and inflammatory biomarkers during omalizumab for chronic spontaneous urticaria
Laura Diluvio, Arianna Piccolo, Francesco Marasco, et al.
Future Science OA (2020) Vol. 6, Iss. 9
Open Access | Times Cited: 11

Plasma adenosine is linked to disease activity and response to treatment in patients with chronic spontaneous urticaria
Manyun Mao, Hong Liu, Siyu Yan, et al.
Allergy (2020) Vol. 76, Iss. 2, pp. 571-573
Closed Access | Times Cited: 10

Serum Amyloid A as a Potential Biomarker for Disease Activity in Chronic Spontaneous Urticaria
A Carvallo, Beatriz Veleiro, Marina Sabaté Brescó, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 12, Iss. 1, pp. 195-200
Open Access | Times Cited: 3

Efficacy and safety of omalizumab therapy in urticaria vasculitis
Fiorella Petrelli, Daiana Giannini, Silvia Bilia, et al.
Frontiers in Allergy (2022) Vol. 3
Open Access | Times Cited: 3

Blood Adhesion Molecules as Biomarkers in Children with Chronic Urticaria
Ioanna Angeli, Εmilia Vassilopoulou, Dimitrios Cassimos, et al.
Children (2024) Vol. 11, Iss. 4, pp. 449-449
Open Access

Assessment of ELR, PLR, NLR and BLR Ratios during Omalizumab Treatment of Chronic Spontaneous Urticaria
Olga Branicka, Barbara Rymarczyk, Radosław Gawlik, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4287-4287
Open Access

Assesment of Salivary and Serum Levels of HBD2 in Patients with Chronic Angioedema
Maja Štrajtenberger, Liborija Lugović‐Mihić, Asja Stipić-Marković, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7552-7552
Open Access

Circulating Pentraxin-3 and its association with C-reactive protein levels and disease activity in patients with chronic spontaneous urticaria
Şengül Beyaz, Serkan Belkaya, Nida Öztop
Allergologia et Immunopathologia (2023) Vol. 51, Iss. 4, pp. 87-93
Open Access | Times Cited: 1

Effect of Allergen-Specific Immunotherapy on Transcriptomic Changes in Canine Atopic Dermatitis
Alicja Majewska, Małgorzata Gajewska, K. Dembele
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11616-11616
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top